We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Controlled Glucose Oscillations May Restore Insulin Production

By HospiMedica International staff writers
Posted on 08 Nov 2016
A new study suggests that administering controlled pulses of glucose via a microfluidic platform has the potential to reestablish normal insulin production and prevent type 2 diabetes.

Developed by researchers at Florida State University (FSU; Tallahassee, FL; USA), the Dual Oscillator Model (DOM) is a mathematical tool that can simulate experiments with the islets of Langerhans, small clusters of pancreatic cells that contain insulin-producing β-cells. More...
The DOM predicted that an oscillatory stimulus using pulses of glucose to the bloodstream has the potential to reactivate the insulin clock within β-cells that had been halted by exposure to excess glucose.

The researchers tested the hypothesis in a non-diabetic islets of Langerhans mice model. Using a specially engineered microfluidic device, they first delivered a high, steady, glucose stream; as expected, the insulin clock within the mouse islets was deactivated. But when controlled pulses of glucose were reapplied to the islets, the insulin clock was restarted. Moreover, when the flow of glucose followed a feedback loop simulating liver activity, the reactivated islets also recruited other islets to restart their insulin clock. The study was published on October 26, 2016, in PLOS Computational Biology.

“Microfluidics and mathematical modeling can be used together to gain new insights into the mechanisms for hormone secretion,” concluded senior author Richard Bertram, PhD, of the FSU department of mathematics and programs in neuroscience and molecular biophysics. “Our results have potential implications for enhancing insulin pulsatility, and therefore mitigating the development of type 2 diabetes.”

Pancreatic islets manage elevations in blood glucose level by secreting insulin into the bloodstream, governed by islet oscillations such as bursting electrical activity and periodic Ca2+ entry in β-cells. In healthy individuals, β-cells release regular pulses of insulin to restrict the amount of glucose released by the liver, as well as impel body tissues to absorb the glucose. However, in hyperglycemia, a hallmark of type 2 diabetes, the excess glucose suppresses the "inner clock" of β-cells that controls the rhythm of insulin pulses, reducing insulin production.

Related Links:
Florida State University



Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: IMX742 CMOS image sensor for single-use endoscopes (Photo courtesy of Sony Semiconductor Solutions Corporation)

Miniature Image Sensor Enables Digital Imaging in Single-Use Endoscopes

Disposable single-use endoscopes are increasingly used to help reduce infection risk and the burden of post-procedure reprocessing and equipment management. As insertion sections become thinner, endoscopic... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.